<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2020/03/12/2020.03.12.977918.atom" />
<meta name="HW.pisa" content="biorxiv;2020.03.12.977918v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors" />
<meta name="DC.Identifier" content="10.1101/2020.03.12.977918" />
<meta name="DC.Date" content="2020-03-12" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), CC BY-NC 4.0, as described at http://creativecommons.org/licenses/by-nc/4.0/" />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="Background Nipah Virus (NiV) came into limelight recently due to an outbreak in Kerala, India. NiV causes severe disease and death in people with over 75% case fatality rate. It is a public health concern and has the potential to become a global pandemic. Lack of treatment has forced the containment methods to be restricted to isolation and surveillance. WHO’s ‘R&amp;D Blueprint list of priority diseases’ (2018) indicates that there is an urgent need for accelerated research &amp; development for addressing NiV.

Materials &amp; Methods In the quest for druglike NiV inhibitors (NVIs) a thorough literature search followed by systematic data curation was conducted. Rigorous data analysis was done with curated NVIs for prioritizing druglike compounds. For the same, more than 1800 descriptors of NVIs were computed and comparative analysis was performed with the FDA approved small molecules and antivirals. These compounds were further evaluated through PAINS filter to study their toxicity profile. Simultaneously, compounds were also prioritized based on the robustness of the assays through which they were identified.

Results Our efforts lead to the creation of a well-curated structured knowledgebase of 182 NVIs with 98 small molecule inhibitors. The reported IC50/EC50 values for some of these inhibitors are in the nanomolar range – as low as 0.47 nM. In order to prioritize these inhibitors, we performed several tests and applied filters to identify drug-like non-toxic compounds. Of 98, a few compounds passed DruLito &amp; PAINS filters exhibiting drug-like properties and were also prioritized in an independent screen based only the assay robustness. The NVIs have diverse structural features and offer a wide spectrum of ways in which they can be developed further as druglike molecules.

Conclusion We report a knowledgebase for furthering the development of NVIs. The platform has a diverse set of 98 NVIs of which a few have been prioritized based on a combined evidence strategy. The platform has the provision to submit new inhibitors as and when reported by the community for further enhancement of NiV inhibitor landscape.

*   FDA
    :   Food and Drug Administration,
    NVIs
    :   Nipah Virus Inhibitors,
    Niv
    :   Nipah Virus,
    WHO
    :   World Health Organization,
    R&amp;D
    :   Research and Development,
    PAINS
    :   Pan-assay interference compounds,
    IC50
    :   Half maximal inhibitory concentration,
    EC50
    :   half-maximal effective concentration,
    NVIK
    :   Nipah Virus Inhibitor Knowledgebase,
    NVIC
    :   Nipah Virus Inhibitor Collection,
    LAMP
    :   Linux-Apache-Mysql-PHP,
    SMILES: SDF
    :   structure data file,
    Nneib
    :   Near Neighbour,
    TopoPSA
    :   topological polar surface area,
    NADH
    :   Nicotinamide adenine dinucleotide." />
<meta name="DC.Contributor" content="Nishi Kumari" />
<meta name="DC.Contributor" content="Ayush Upadhyay" />
<meta name="DC.Contributor" content="Kishan Kalia" />
<meta name="DC.Contributor" content="Rakesh Kumar" />
<meta name="DC.Contributor" content="Kanika Tuteja" />
<meta name="DC.Contributor" content="Priyanka Rani Paul" />
<meta name="DC.Contributor" content="Eugenia Covernton" />
<meta name="DC.Contributor" content="Tina Sharma" />
<meta name="DC.Contributor" content="Vinod Scaria" />
<meta name="DC.Contributor" content="Anshu Bhardwaj" />
<meta name="article:published_time" content="2020-03-12" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors" />
<meta name="citation_abstract" lang="en" content="&lt;p&gt;Background: Nipah Virus (NiV) came into limelight recently due to an outbreak in Kerala, India. NiV causes severe disease and death in people with over 75% case fatality rate. It is a public health concern and has the potential to become a global pandemic. Lack of treatment has forced the containment methods to be restricted to isolation and surveillance. WHOs R&amp;amp;D Blueprint list of priority diseases (2018) indicates that there is an urgent need for accelerated research &amp;amp; development for addressing NiV. Materials &amp;amp; Methods: In the quest for druglike NiV inhibitors (NVIs) a thorough literature search followed by systematic data curation was conducted. Rigorous data analysis was done with curated NVIs for prioritizing druglike compounds. For the same, more than 1800 descriptors of NVIs were computed and comparative analysis was performed with the FDA approved small molecules and antivirals. These compounds were further evaluated through PAINS filter to study their toxicity profile. Simultaneously, compounds were also prioritized based on the robustness of the assays through which they were identified. Results: Our efforts lead to the creation of a well-curated structured knowledgebase of 182 NVIs with 98 small molecule inhibitors. The reported IC50/EC50 values for some of these inhibitors are in the nanomolar range as low as 0.47 nM. In order to prioritize these inhibitors, we performed several tests and applied filters to identify drug-like non-toxic compounds. Of 98, a few compounds passed DruLito &amp;amp; PAINS filters exhibiting drug-like properties and were also prioritized in an independent screen based only the assay robustness. The NVIs have diverse structural features and offer a wide spectrum of ways in which they can be developed further as druglike molecules. Conclusion: We report a knowledgebase for furthering the development of NVIs. The platform has a diverse set of 98 NVIs of which a few have been prioritized based on a combined evidence strategy. The platform has the provision to submit new inhibitors as and when reported by the community for further enhancement of NiV inhibitor landscape. Resource available at http://bioinfo.imtech.res.in/anshu/nipah/&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2020/01/01" />
<meta name="citation_mjid" content="biorxiv;2020.03.12.977918v1" />
<meta name="citation_id" content="2020.03.12.977918v1" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918.full.pdf" />
<meta name="citation_doi" content="10.1101/2020.03.12.977918" />
<meta name="citation_num_pages" content="14" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="2020.03.12.977918" />
<meta name="citation_author" content="Nishi Kumari" />
<meta name="citation_author_institution" content="Department of Biotechnology, University Institute of Engineering and Technology, Panjab University" />
<meta name="citation_author" content="Ayush Upadhyay" />
<meta name="citation_author_institution" content="Department of Microbiology, Bhaskaracharya College of Applied Sciences, Delhi University" />
<meta name="citation_author" content="Kishan Kalia" />
<meta name="citation_author_institution" content="Department of Biotechnology and Bioinformatics, D.A.V. College" />
<meta name="citation_author" content="Rakesh Kumar" />
<meta name="citation_author_institution" content="Bioinformatics Centre, CSIR-Institute of Microbial Technology" />
<meta name="citation_author_institution" content="Academy of Scientific and Innovative Research (AcSIR), CSIR-Institute of Microbial Technology" />
<meta name="citation_author" content="Kanika Tuteja" />
<meta name="citation_author_institution" content="Centre of Systems Biology and Bioinformatics, Panjab University" />
<meta name="citation_author" content="Priyanka Rani Paul" />
<meta name="citation_author_institution" content="Department of Biochemistry, University of Lucknow" />
<meta name="citation_author" content="Eugenia Covernton" />
<meta name="citation_author_institution" content="Centre de recherches interdisciplinaires" />
<meta name="citation_author" content="Tina Sharma" />
<meta name="citation_author_institution" content="Bioinformatics Centre, CSIR-Institute of Microbial Technology" />
<meta name="citation_author_institution" content="Academy of Scientific and Innovative Research (AcSIR), CSIR-Institute of Microbial Technology" />
<meta name="citation_author" content="Vinod Scaria" />
<meta name="citation_author_institution" content="CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB)" />
<meta name="citation_author" content="Anshu Bhardwaj" />
<meta name="citation_author_institution" content="Bioinformatics Centre, CSIR-Institute of Microbial Technology" />
<meta name="citation_author_email" content="anshu@imtech.res.in" />
<meta name="citation_author_orcid" content="http://orcid.org/0000-0001-5830-2616" />
<meta name="citation_reference" content="Wang LF, Harcourt BH, Yu M et al. Molecular biology of Hendra and Nipah viruses. Microbes Infect. 2001; 3: 279–287." />
<meta name="citation_reference" content="Ang BSP, Lim TCC, Wang L. Nipah virus infection. J Clin Microbiol 2018; 56. doi: 10.1128/JCM.01875-17." />
<meta name="citation_reference" content="Halpin K, Hyatt AD, Fogarty R et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: A comprehensive experimental study of virus transmission. Am J Trop Med Hyg 2011; 85: 946–951." />
<meta name="citation_reference" content="Centers for Disease Control and Prevention (CDC). Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48: 265–9." />
<meta name="citation_reference" content="Parashar UD, Sunn LM, Ong F et al. Case□Control Study of Risk Factors for Human Infection with a New Zoonotic Paramyxovirus, Nipah Virus, during a 1998–1999 Outbreak of Severe Encephalitis in Malaysia. J Infect Dis 2000; 181: 1755–1759." />
<meta name="citation_reference" content="Hsu VP, Hossain MJ, Parashar UD et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis 2004; 10: 2082–2087." />
<meta name="citation_reference" content="Nipah Virus Distribution Map | Nipah Virus (NiV) | CDC. https://www.cdc.gov/vhf/nipah/outbreaks/distribution-map.html (accessed 11 Nov2019)." />
<meta name="citation_reference" content="World Health Organization, Nipah virus outbreaks in the WHO South-East Asia Region. http://www.searo.who.int/entity/emerging_diseases/links/nipah_virus_outbreaks_sear/en/ (accessed 11 Nov2019)." />
<meta name="citation_reference" content="Chadha MS, Comer JA, Lowe L et al. Nipah virus-associated encephalitis outbreak, Siliguri, India. Emerg Infect Dis 2006; 12: 235–240." />
<meta name="citation_reference" content="Luby SP, Gurley ES, Hossain MJ. Transmission of Human Infection with Nipah Virus. Clin Infect Dis 2009; 49: 1743–1748." />
<meta name="citation_reference" content="WHO | Nipah virus – India. https://www.who.int/csr/don/07-august-2018-nipah-virus-india/en/ (accessed 11 Nov2019)." />
<meta name="citation_reference" content="23-year-old student infected with Nipah virus, confirms Kerala govt - The Hindu. https://www.thehindu.com/news/national/kerala/one-confirmed-case-of-nipah-in-kochi/article27437677.ece (accessed 11 Nov2019)." />
<meta name="citation_reference" content="Maisner A, Neufeld J, Weingartl H. Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro. Thromb. Haemost. 2009; 102: 1014–1023." />
<meta name="citation_reference" content="Diederich S, Thiel L, Maisner A. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology 2008; 375: 391–400." />
<meta name="citation_reference" content="Kulkarni S, Volchkova V, Basler CF, Palese P, Volchkov VE, Shaw ML. Nipah Virus Edits Its P Gene at High Frequency To Express the V and W Proteins. J Virol 2009; 83: 3982–3987." />
<meta name="citation_reference" content="Lam S-K. Nipah virus--a potential agent of bioterrorism? Antiviral Res 2003; 57: 113–9." />
<meta name="citation_reference" content="Snell NJC. Ribavirin Therapy for Nipah Virus Infection. J Virol 2004; 78: 10211–10211." />
<meta name="citation_reference" content="Chong HT, Kamarulzaman A, Tan CT et al. Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol 2001; 49: 810–813." />
<meta name="citation_reference" content="Georges-Courbot MC, Contamin H, Faure C et al. Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother 2006; 50: 1768–1772." />
<meta name="citation_reference" content="Dawes BE, Kalveram B, Ikegami T et al. Favipiravir (T-705) protects against Nipah virus infection in the hamster model /631/326/22/1295 /631/326/596/1296 /13/106 /14/35 /38/77 /82/51 /96/63 article. Sci Rep 2018; 8. doi: 10.1038/s41598-018-25780-3." />
<meta name="citation_reference" content="Lo MK, Feldmann F, Gary JM et al. Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge. Sci Transl Med 2019; 11. doi: 10.1126/scitranslmed.aau9242." />
<meta name="citation_reference" content="Prioritizing diseases for research and development in emergency contexts. https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-context (accessed 12 Nov2019)." />
<meta name="citation_reference" content="Tigabu B, Rasmussen L, White EL et al. A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus. Assay Drug Dev Technol 2014; 12: 155–161." />
<meta name="citation_reference" content="García-Murria MJ, Expósito-Domínguez N, Duart G, Mingarro I, Martinez-Gil L. A bimolecular multicellular complementation system for the detection of syncytium formation: A new methodology for the identification of Nipah virus entry inhibitors. Viruses 2019; 11. doi: 10.3390/v11030229." />
<meta name="citation_reference" content="Dang H V., Chan Y-P, Park Y-J et al. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections. Nat Struct Mol Biol 2019; 26: 980–987." />
<meta name="citation_reference" content="Zhang Y, Aevermann BD, Anderson TK et al. Influenza Research Database: An integrated bioinformatics resource for influenza virus research. Nucleic Acids Res 2017; 45: D466–D474." />
<meta name="citation_reference" content="De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 2016; 29: 695–747." />
<meta name="citation_reference" content="Pickett BE, Greer DS, Zhang Y et al. Virus pathogen Database and Analysis Resource (ViPR): A comprehensive bioinformatics Database and Analysis Resource for the Coronavirus research community. Viruses 2012; 4: 3209–3226." />
<meta name="citation_reference" content="Rajput A, Kumar A, Kumar M. Computational identification of inhibitors using QSAR approach against Nipah virus. Front Pharmacol 2019; 10. doi: 10.3389/fphar.2019.00071." />
<meta name="citation_reference" content="Yap CW. PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J Comput Chem 2011; 32: 1466–1474" />
<meta name="citation_reference" content="Krzywinski M, Schein J, Birol I et al. Circos: An information aesthetic for comparative genomics. Genome Res 2009; 19: 1639–1645." />
<meta name="citation_reference" content="Sharma A, Dutta P, Sharma M et al. BioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts. J Cheminform 2014; 6: 46." />
<meta name="citation_reference" content="Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates. J Med Chem 2002; 45: 2615–2623." />
<meta name="citation_reference" content="Oprea TI. Property distribution of drug-related chemical databases. J Comput Aided Mol Des 2000; 14: 251–64." />
<meta name="citation_reference" content="Bickerton GR, Paolini G V., Besnard J, Muresan S, Hopkins AL. Quantifying the chemical beauty of drugs. Nat Chem 2012; 4: 90–98." />
<meta name="citation_reference" content="Ghose AK, Viswanadhan VN, Wendoloski JJ. A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases. J Comb Chem 1999; 1: 55–68." />
<meta name="twitter:title" content="A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="Background Nipah Virus (NiV) came into limelight recently due to an outbreak in Kerala, India. NiV causes severe disease and death in people with over 75% case fatality rate. It is a public health concern and has the potential to become a global pandemic. Lack of treatment has forced the containment methods to be restricted to isolation and surveillance. WHO’s ‘R&amp;D Blueprint list of priority diseases’ (2018) indicates that there is an urgent need for accelerated research &amp; development for addressing NiV.

Materials &amp; Methods In the quest for druglike NiV inhibitors (NVIs) a thorough literature search followed by systematic data curation was conducted. Rigorous data analysis was done with curated NVIs for prioritizing druglike compounds. For the same, more than 1800 descriptors of NVIs were computed and comparative analysis was performed with the FDA approved small molecules and antivirals. These compounds were further evaluated through PAINS filter to study their toxicity profile. Simultaneously, compounds were also prioritized based on the robustness of the assays through which they were identified.

Results Our efforts lead to the creation of a well-curated structured knowledgebase of 182 NVIs with 98 small molecule inhibitors. The reported IC50/EC50 values for some of these inhibitors are in the nanomolar range – as low as 0.47 nM. In order to prioritize these inhibitors, we performed several tests and applied filters to identify drug-like non-toxic compounds. Of 98, a few compounds passed DruLito &amp; PAINS filters exhibiting drug-like properties and were also prioritized in an independent screen based only the assay robustness. The NVIs have diverse structural features and offer a wide spectrum of ways in which they can be developed further as druglike molecules.

Conclusion We report a knowledgebase for furthering the development of NVIs. The platform has a diverse set of 98 NVIs of which a few have been prioritized based on a combined evidence strategy. The platform has the provision to submit new inhibitors as and when reported by the community for further enhancement of NiV inhibitor landscape.

*   FDA
    :   Food and Drug Administration,
    NVIs
    :   Nipah Virus Inhibitors,
    Niv
    :   Nipah Virus,
    WHO
    :   World Health Organization,
    R&amp;D
    :   Research and Development,
    PAINS
    :   Pan-assay interference compounds,
    IC50
    :   Half maximal inhibitory concentration,
    EC50
    :   half-maximal effective concentration,
    NVIK
    :   Nipah Virus Inhibitor Knowledgebase,
    NVIC
    :   Nipah Virus Inhibitor Collection,
    LAMP
    :   Linux-Apache-Mysql-PHP,
    SMILES: SDF
    :   structure data file,
    Nneib
    :   Near Neighbour,
    TopoPSA
    :   topological polar surface area,
    NADH
    :   Nicotinamide adenine dinucleotide." />
<meta name="og-title" property="og:title" content="A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="Background Nipah Virus (NiV) came into limelight recently due to an outbreak in Kerala, India. NiV causes severe disease and death in people with over 75% case fatality rate. It is a public health concern and has the potential to become a global pandemic. Lack of treatment has forced the containment methods to be restricted to isolation and surveillance. WHO’s ‘R&amp;D Blueprint list of priority diseases’ (2018) indicates that there is an urgent need for accelerated research &amp; development for addressing NiV.

Materials &amp; Methods In the quest for druglike NiV inhibitors (NVIs) a thorough literature search followed by systematic data curation was conducted. Rigorous data analysis was done with curated NVIs for prioritizing druglike compounds. For the same, more than 1800 descriptors of NVIs were computed and comparative analysis was performed with the FDA approved small molecules and antivirals. These compounds were further evaluated through PAINS filter to study their toxicity profile. Simultaneously, compounds were also prioritized based on the robustness of the assays through which they were identified.

Results Our efforts lead to the creation of a well-curated structured knowledgebase of 182 NVIs with 98 small molecule inhibitors. The reported IC50/EC50 values for some of these inhibitors are in the nanomolar range – as low as 0.47 nM. In order to prioritize these inhibitors, we performed several tests and applied filters to identify drug-like non-toxic compounds. Of 98, a few compounds passed DruLito &amp; PAINS filters exhibiting drug-like properties and were also prioritized in an independent screen based only the assay robustness. The NVIs have diverse structural features and offer a wide spectrum of ways in which they can be developed further as druglike molecules.

Conclusion We report a knowledgebase for furthering the development of NVIs. The platform has a diverse set of 98 NVIs of which a few have been prioritized based on a combined evidence strategy. The platform has the provision to submit new inhibitors as and when reported by the community for further enhancement of NiV inhibitor landscape.

*   FDA
    :   Food and Drug Administration,
    NVIs
    :   Nipah Virus Inhibitors,
    Niv
    :   Nipah Virus,
    WHO
    :   World Health Organization,
    R&amp;D
    :   Research and Development,
    PAINS
    :   Pan-assay interference compounds,
    IC50
    :   Half maximal inhibitory concentration,
    EC50
    :   half-maximal effective concentration,
    NVIK
    :   Nipah Virus Inhibitor Knowledgebase,
    NVIC
    :   Nipah Virus Inhibitor Collection,
    LAMP
    :   Linux-Apache-Mysql-PHP,
    SMILES: SDF
    :   structure data file,
    Nneib
    :   Near Neighbour,
    TopoPSA
    :   topological polar surface area,
    NADH
    :   Nicotinamide adenine dinucleotide." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2020-03-12" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2020.03.12.977918v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2020.03.12.977918v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2020.03.12.977918v1.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1" />
<link rel="shortlink" href="https://www.biorxiv.org/node/1193413" />
    <title>A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__GFpBMW7A95ZNl4oKhiI_0u7WD_8tFHiDfbKIVNkYgis__uourhtZYS_vAk2DtacwQIGmpE376HP4afgwMlmHZpq0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"2Q_ylidIHBHzzpZsM4p8drrDtth6g4xQaSHHrNeDUsQ","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_tables.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"1193413","apath":"\/biorxiv\/early\/2020\/03\/12\/2020.03.12.977918.atom","pisa":"biorxiv;2020.03.12.977918v1","processed":["highwire_math"],"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;2020.03.12.977918v1"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/2020.03.12.977918v1","title":"A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors","identifier":"node\/1193413"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022I4CGalEvg8z25t5WIuaPOp2B9u5UB\\\\\\\/ykMdl0Be3Vxo55Gtx0O72MLGjrTOL6KK689R159qc2WAFBKIPHLsXNjt0G1QJ2Kyx775Uo9OHjsofmq\\\\\\\/2X6VcfAKJdh3SUo1JH\\\\\\\/7yWZwJJjcslnQhqf2IWnRif6XMdn1Q2Ldr2SDMBCE3WX2i9d3QCxBdEkt1BreGitHO3cBOSBNjMkJVh1QzGi55LqPKigMbadKqpfRuHFyq579JMo4omPZ2+oEhO7XrrcZDMZ5xydRAjvJHtW5zt9yNHpMApQzBE9Qbk4r1R0Nc524im+gFijnst7TL0NAWCReST2Zmx42assnAu1i8+\\\\\\\/1fKe87NTWRQQTKxAVnbzmTrxQ1X1u\\\\\\\/f44t0yOJVhHtWGaWGVr0v\\\\\\\/NTP+2GlegOojJCkKVwlpHUk166i3Fvj+tgAB5NQ0kgNSjACUS+\\\\\\\/balkXDarG0FElZQ0LLGCt3PYJjU+p1XWYu\\\\\\\/fX7PaNNYLKV3EHBgDdbfIvgKkBOsH4p+oERNECC2bOJUZgexdmNLjVeQongw7CGxUJVLsmC\\\\\\\/3NfBKGC4iJl58sPHnA+jLXghOHC9PsZAyIF7CRrKc\\\\\\\/K+U81wTtkr6qx4ZluCzzRwa4pe5QaQraPFqTkW1yxKZUrMmfVlyEmKgsTEl+aky9qAuxRn\\\\\\\/v8UbJmJInqwERAqrtiQposNbyo4yELrxMxdlx1mXbvSRJCz3G4jQ\\\\\\\/\\\\\\\/MY+Iu2143A07WiCy1CPzAGIF4J7veBAt++sT9+DYMudkNsHowCwWxL\\\\\\\/py4nk4OKoV\\\\\\\/Af\\\\\\\/sO6v2PywLMGF\\\\\\\/hpx7MR1fCn12bZoMVH4lluutMcxhBtiunZzRK5rc+\\\\\\\/LZPMi9urO\\\\\\\/ThfkxLWSos4Vw8q7nHCwlFhGvES2lr6YAjQNDhKeIWPjHVhe5gjlKN7pUkIM6f3bhzYfx3HiuEh60n07ZjF2TEdTtjS3OA5Er2cLOsFlAYoEDyiLnMF+O4Z7tekDPgrr7ZiNDT0rlrJkl2EcmPRaQDXr7fENGAEXj2WnyhImVAHiAWDKDzZGhpLe9I4iwCW5y04yn2u5w7qpdquVK32azC06gtJ6MRjhoMx4Uuu3n8Wc9KWZPRMdDbSeEjh949\\\\\\\/fe5uMEZE\\\\\\\/YVynCKVZ710cMcfCbIOY0MMbmUuneWQPZ3MPqvTDtfBLfUCJRfeK2iZUuhlzvlv7FtXnLn+8mA9TKo4hwPv3Z8Ym3ufTmD3Sg0EDwezBuA+OHktc8P777pcK\\\\\\\/07VjFotaWGCvNXU4GD\\\\\\\/iu2xAZd4ox6znj+\\\\\\\/Nw97HiPL6rmeFvHTgyXIU5uFx9ouyjZqItXpUmw5Vfd0b7gIHgF+GLeKjMcMItvlUyH3z\\\\\\\/dS\\\u0022,\\\u0022iv\\\u0022:\\\u00221a6JqUpbeC88Tnr3DDff3A==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u002268b74c8fd2008141163ff0cb1286cc5edee100f4ba402055ecc1bcdb522977f2\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2020.03.12.977918v1.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-1193413 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2020.03.12.977918v1.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-fQIP-sfZNQQTp-BY7IVaMfMQPo_pPV8dcihAebENGMs" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1193413" id="node1193413" data-pisa="biorxiv;2020.03.12.977918v1" data-pisa-master="biorxiv;2020.03.12.977918" data-apath="/biorxiv/early/2020/03/12/2020.03.12.977918.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Nishi</span> <span class="nlm-surname">Kumari</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Ayush</span> <span class="nlm-surname">Upadhyay</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Kishan</span> <span class="nlm-surname">Kalia</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Rakesh</span> <span class="nlm-surname">Kumar</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kanika</span> <span class="nlm-surname">Tuteja</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Priyanka Rani</span> <span class="nlm-surname">Paul</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Eugenia</span> <span class="nlm-surname">Covernton</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Tina</span> <span class="nlm-surname">Sharma</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Vinod</span> <span class="nlm-surname">Scaria</span></span>, <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="9"><a href="http://orcid.org/0000-0001-5830-2616" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon"><i class="hw-icon-orcid hw-icon-color-orcid"></i> <span class="title element-invisible">View ORCID Profile</span></a><span class="nlm-given-names">Anshu</span> <span class="nlm-surname">Bhardwaj</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/2020.03.12.977918 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node1193413" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Nishi Kumari </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Biotechnology, University Institute of Engineering and Technology, Panjab University</span>, Chandigarh, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Nishi%2BKumari%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Kumari%20N&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ANishi%2BKumari%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Ayush Upadhyay </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Department of Microbiology, Bhaskaracharya College of Applied Sciences, Delhi University</span>, New Delhi, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Ayush%2BUpadhyay%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Upadhyay%20A&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AAyush%2BUpadhyay%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Kishan Kalia </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Department of Biotechnology and Bioinformatics, D.A.V. College</span>, Sector-10, Chandigarh, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Kishan%2BKalia%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Kalia%20K&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AKishan%2BKalia%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Rakesh Kumar </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Bioinformatics Centre, CSIR-Institute of Microbial Technology</span>, Chandigarh, <span class='nlm-country'>India</span></div><div class='author-affiliation'><span class='nlm-sup'>9</span><span class='nlm-institution'>Academy of Scientific and Innovative Research (AcSIR), CSIR-Institute of Microbial Technology</span>, Chandigarh. <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Rakesh%2BKumar%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Kumar%20R&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ARakesh%2BKumar%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Kanika Tuteja </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>5</span><span class='nlm-institution'>Centre of Systems Biology and Bioinformatics, Panjab University</span>, Chandigarh, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Kanika%2BTuteja%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Tuteja%20K&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AKanika%2BTuteja%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Priyanka Rani Paul </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>6</span><span class='nlm-institution'>Department of Biochemistry, University of Lucknow</span>, Lucknow, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Priyanka%2BRani%2BPaul%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Paul%20PR&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3APriyanka%2BRani%2BPaul%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Eugenia Covernton </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>7</span><span class='nlm-institution'>Centre de recherches interdisciplinaires</span>, Paris, <span class='nlm-country'>France</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Eugenia%2BCovernton%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Covernton%20E&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AEugenia%2BCovernton%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-7"><div class="author-tooltip-name">Tina Sharma </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Bioinformatics Centre, CSIR-Institute of Microbial Technology</span>, Chandigarh, <span class='nlm-country'>India</span></div><div class='author-affiliation'><span class='nlm-sup'>9</span><span class='nlm-institution'>Academy of Scientific and Innovative Research (AcSIR), CSIR-Institute of Microbial Technology</span>, Chandigarh. <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Tina%2BSharma%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Sharma%20T&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ATina%2BSharma%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-8"><div class="author-tooltip-name">Vinod Scaria </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>8</span><span class='nlm-institution'>CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB)</span>, South Campus, Mathura Road, New Delhi, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Vinod%2BScaria%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Scaria%20V&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AVinod%2BScaria%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-9"><div class="author-tooltip-name">Anshu Bhardwaj </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Bioinformatics Centre, CSIR-Institute of Microbial Technology</span>, Chandigarh, <span class='nlm-country'>India</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Anshu%2BBhardwaj%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Bhardwaj%20A&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AAnshu%2BBhardwaj%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-orcid-link"><a href="http://orcid.org/0000-0001-5830-2616" target="_blank" class="" data-icon-position="" data-hide-link-title="0">ORCID record for Anshu Bhardwaj</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:anshu@imtech.res.in" class="" data-icon-position="" data-hide-link-title="0">anshu@imtech.res.in</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/2020.03.12.977918v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:1193413" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:1193413/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.03.12.977918v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:1193413" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:1193413/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.03.12.977918v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:1193413" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:1193413/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/2020.03.12.977918v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:1193413" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:1193413/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/2020.03.12.977918v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:1193413" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:1193413/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><div id="sec-1" class="subsection"><p id="p-2"><strong>Background</strong> Nipah Virus (NiV) came into limelight recently due to an outbreak in Kerala, India. NiV causes severe disease and death in people with over 75% case fatality rate. It is a public health concern and has the potential to become a global pandemic. Lack of treatment has forced the containment methods to be restricted to isolation and surveillance. WHO’s ‘R&amp;D Blueprint list of priority diseases’ (2018) indicates that there is an urgent need for accelerated research &amp; development for addressing NiV.</p></div><div id="sec-2" class="subsection"><p id="p-3"><strong>Materials &amp; Methods</strong> In the quest for druglike NiV inhibitors (NVIs) a thorough literature search followed by systematic data curation was conducted. Rigorous data analysis was done with curated NVIs for prioritizing druglike compounds. For the same, more than 1800 descriptors of NVIs were computed and comparative analysis was performed with the FDA approved small molecules and antivirals. These compounds were further evaluated through PAINS filter to study their toxicity profile. Simultaneously, compounds were also prioritized based on the robustness of the assays through which they were identified.</p></div><div id="sec-3" class="subsection"><p id="p-4"><strong>Results</strong> Our efforts lead to the creation of a well-curated structured knowledgebase of 182 NVIs with 98 small molecule inhibitors. The reported IC50/EC50 values for some of these inhibitors are in the nanomolar range – as low as 0.47 nM. In order to prioritize these inhibitors, we performed several tests and applied filters to identify drug-like non-toxic compounds. Of 98, a few compounds passed DruLito &amp; PAINS filters exhibiting drug-like properties and were also prioritized in an independent screen based only the assay robustness. The NVIs have diverse structural features and offer a wide spectrum of ways in which they can be developed further as druglike molecules.</p></div><div id="sec-4" class="subsection"><p id="p-5"><strong>Conclusion</strong> We report a knowledgebase for furthering the development of NVIs. The platform has a diverse set of 98 NVIs of which a few have been prioritized based on a combined evidence strategy. The platform has the provision to submit new inhibitors as and when reported by the community for further enhancement of NiV inhibitor landscape.</p></div></div><div class="section" id="sec-5"><h2 class="">Introduction</h2><p id="p-6">Nipah is an infectious negative-sense single-stranded RNA virus which belongs to the genus henipavirus and family Paramyxoviridae [<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>]. It is a pleomorphic enveloped virus with a particle size ranging from 40 to 1,900nm [<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>]. While fruit bats are thought to be the natural reservoirs of the virus, they are also able to spread to humans and some other species [<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>]. There are two major genetic lineages of the virus which are known to infect humans i.e, NIV Malaysia (NIV<sub>M</sub>) and NIV Bangladesh (NIV<sub>B</sub>) [<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>].</p><p id="p-7">The first outbreak of Nipah virus infection erupted between September 29,1998, and April 4, 1999, when cases of febrile encephalitis in the suburb of Ipoh, Perak, Southern Peninsular Malaysia were reported to the Malaysian Ministry of Health (MOH) [<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>]. It was traced back to cross-species transmission of the virus from pigs to humans [<a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>,<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>]. In 2001 another strain of the virus was reported to cause an outbreak in Meherpur, Bangladesh. Since then outbreaks have been recorded almost annually in the country and surrounding regions such as Siliguri, India [<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>,<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>]. Most of the outbreaks have been observed to have a mortality rate ranging from 50-100% [<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>]. Although direct contact with the infected bat’s contaminants could cause transmission of the virus, direct human-to-human transmission has also been observed in the case of healthcare professionals and relatives of infected patients [<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>,<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>]. More recently, the virus has garnered attention due to the first-ever outbreak in southern India during May of 2018 where 19 cases of NiV were reported in Kozhikode, Kerala. In the subsequent year, 2019, another case was reported in Ernakulam district of the state [<a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>,<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>].</p><p id="p-8">Nipah virus causes cell-to-cell fusion in the host thus forming multinucleated cells called syncytia. This allows the virus to spread despite the absence of viral budding and greatly influences its pathogenicity [<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>,<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>]. The incubation period of the virus ranges from 5 to 14 days (<a href="https://www.cdc.gov/vhf/nipah/pdf/factsheet.pdf">https://www.cdc.gov/vhf/nipah/pdf/factsheet.pdf</a>). Primarily the virus infects the central nervous system but the NIV<sub>B</sub> strain has been shown to have significant respiratory involvement [<a id="xref-ref-2-3" class="xref-bibr" href="#ref-2">2</a>]. High mutation rate, human to human transmission, survival time of up to 4 days under various environmental conditions and lack of treatment makes it a potential bioterrorism agent [<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>,<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>].</p><p id="p-9">Currently, there is no known treatment for the disease. Broad-spectrum antiviral ribavirin has shown contradictory results with even the most optimistic ones significantly below 50% in causing reduction of the mortality rate [<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>,<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>,<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>]. Favipiravir (T-705), a purine analogue antiviral, is reported to provide protection to upto 14 days in the Syrian hamster model challenged with a lethal dose of Nipah virus [<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>]. More recently, experimental drug remdesivir has demonstrated complete protection to four African green monkeys who received a lethal dose of Nipah virus. Studies are planned to assess the efficacy of the treatment over time [<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>]. Despite being a lethal pathogen there is not a single drug under clinical trial against this virus. Due to several challenges in discovery and development of NVIs, along with lack of therapeutic intervention and the pathogenic propensity of the virus, Nipah infections are enlisted amongst WHO’s list of priority diseases [<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>].</p><p id="p-10">As mentioned above, various groups have made efforts over the years to identify Nipah virus inhibitors using a variety of viral assays. Most of them have used syncytia formation or titre reduction assays to identify Nipah virus inhibitors. Some of the earlier studies report nipah inhibitors based on screening of large libraries within BSL-4 settings to identify compounds that inhibited the virus-induced cytopathic effect. Three sulfonamide compounds with low EC50 values are reported [<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>] from these screens. More recently, Bimolecular Multicellular Complementation assays have been developed which can be used to identify potential anti-nipah inhibitors by qualitatively and quantitatively investigating the formation of a syncytium [<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>]. Also reported recently is a humanized monoclonal antibody for cross-neutralizing NiV and HeV. Cryo-electron microscopy followed by fusion studies demonstrated that the antibody binds to a prefusion-specific quaternary epitope which is conserved in NiV F and HeV F glycoproteins. The binding prevents membrane fusion and viral entry and clearly indicates the importance of the HNV prefusion F conformation for eliciting a robust immune response [<a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>].</p><p id="p-11">Despite reports of nipah virus inhibitors, no systematic evaluation of the reported compounds is performed. A few antiviral inhibitor databases and studies exist, namely, The Influenza Research Database (IRD) [<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>][<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>], The Virus Pathogen Database and Analysis Resource (ViPR) [<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>], enamine library (<a href="https://enamine.net/hit-finding/focused-libraries/view-all/antiviral-library">https://enamine.net/hit-finding/focused-libraries/view-all/antiviral-library</a>), etc. They contain very limited or no information with the focus on Nipah virus. The ones with focus on Nipah virus inhibitors are either scattered datasets or curated versions with limited or no evaluation of the anti-Nipah compounds as starting points for drug discovery and development of anti-Nipah inhibitor(s) [<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>].</p><p id="p-12">Towards this, we developed a combined evidence based strategy to systematically evaluate Nipah virus inhibitors. With this objective, we curated the anti-Nipah compounds using a crowdsourcing model and the data were made publicly available at – <a href="http://vinodscaria.rnabiology.org/nipah">http://vinodscaria.rnabiology.org/nipah</a> since the inception of the project (May 2018). Our two pronged strategy comprised of (i) prioritization of NVIs based on the robustness of the assays which were used to identify them and (ii) estimation of several drug likeness parameters for the NVIs. The drug likeness analysis includes diversity analysis, similarity to FDA approved compounds (as drug repurposing candidates) or reported antivirals (to identify new scaffolds), profiling based on PAINS and DruLito filters and comparison to ZINC lead like libraries. The data curated from literature along with all these analyses is made available on a web-based platform which also allows submission and assessment of new molecules reported as NVIs.</p></div><div class="section" id="sec-6"><h2 class="">Material and Methods</h2><div id="sec-7" class="subsection"><h3>1.1 Data source and structure</h3><p id="p-13">PubMed (<a href="https://www.ncbi.nlm.nih.gov/pubmed">https://www.ncbi.nlm.nih.gov/pubmed</a>) and Google (<a href="https://www.google.com/">https://www.google.com/</a>) were the two main sources considered for collecting the inhibitors that showed activity against Nipah virus. Research papers relevant to the study were downloaded using the query as ‘Nipah’ and those with the keyword in their abstract/title were shortlisted. At the time of curation this keyword listed 838 papers which were considered for data-mining. This step was followed by a scoring system wherein papers that had confirmed information regarding the inhibitors against Nipah virus in their abstracts were assigned a score of ‘10’, those that may or may not have information regarding the same were given a score of ‘5’, those with information on peptides used as inhibitors were assigned a score of ‘4’ and rest with no relevant information were given a score of ‘0’. Papers with score values of 10, 5 and 4 were considered for further study and all of them were manually curated to create a Nipah Virus Inhibitor Knowledgebase (NVIK) sheet which is used by all the curators to organize data based on a predefined data structure shown below in <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">Table 1</a>.</p><div id="T1" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1198483/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup"><a href="/highwire/markup/1198483/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/1198483" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div></div><div class="table-caption"><span class="table-label">Table 1:</span> <span class="caption-title">Data structure for NVIK</span><div class="sb-div caption-clear"></div></div></div><p id="p-14">For the structure of the inhibitors, MarvinSketch 5.11.4 software from ChemAxon (<a href="https://chemaxon.com/">https://chemaxon.com/</a>) was used and the corresponding ChemSpider (<a href="http://www.chemspider.com/">http://www.chemspider.com/</a>) and PubChem (<a href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</a>) Ids were fetched. These structures were either taken directly from the original paper or the references mentioned in it. Else they were retrieved directly from the company which sourced the compounds initially in the original paper. Repurposed drugs were given DrugBank Id. All inhibitors were given a unique Id. EC50/ IC50 values are mentioned in nM &amp; uM units.</p></div><div id="sec-8" class="subsection"><h3>1.2 Data quality check</h3><p id="p-15">In order to ensure data quality, a separate team of curators re-performed the curation independent of the initial team. Errors are marked in ‘Red’ in the curation sheet and was then marked ‘Green’ once the data is verified by both the teams. Data curation and quality check was done manually and the data is stored in NVIK-Open resource Sheet which served as the crowdsourcing platform. Each entry was tagged with its contributor’s email Id.</p></div><div id="sec-9" class="subsection"><h3>1.3 Platform architecture</h3><p id="p-16">The Nipah Virus Inhibitor Knowledgebase (NVIK) is developed using the open source LAMP (Linux-Apache-Mysql-PHP) server technology. We have also used PHP, HTML, JavaScript, AJAX and CSS. The web-interface has provision for text, structure and complex query based search and other options for browsing.</p></div></div><div class="section" id="sec-10"><h2 class="">Utility</h2><div id="sec-11" class="subsection"><h3>2 User interface</h3><p id="p-17">NVIK is designed as a platform to browse, search and submit NVIs. The search tools are described below. A submission form has been provided that can be used to submit new compounds in the database. The database also lists database statistics along with the physicochemical properties of the compound.</p><div id="sec-12" class="subsection"><h4>2.1 Search tools</h4><p id="p-18">In the NVIK web interface, three search options are available, namely, ‘Simple Search’, ‘Query Builder’ and ‘Structure Search’. The Simple Search option is to retrieve information using a text-based query on all/selected fields of the database. User can selectively display the searched records. Overall, the database contains – unique fields as shown in <a id="xref-fig-1-1" class="xref-fig" href="#F1">Figure 1</a>.</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="NVIK architecture illustrating various fields with &#x2018;Search&#x2019; options, &#x2018;Browse by&#x2019; options and structural &#x2018;similarity&#x2019; options." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1635326302" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;NVIK architecture illustrating various fields with &#x2018;Search&#x2019; options, &#x2018;Browse by&#x2019; options and structural &#x2018;similarity&#x2019; options.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 1:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F1.medium.gif" width="440" height="329"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 1:" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F1.medium.gif" width="440" height="329"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1:" data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">Figure 1:</span> <p id="p-19" class="first-child">NVIK architecture illustrating various fields with ‘Search’ options, ‘Browse by’ options and structural ‘similarity’ options.</p><div class="sb-div caption-clear"></div></div></div><p id="p-20">NVIK’s query builder option enables search using complex queries with the help of logical operators such as AND &amp; OR. With these options, the user can retrieve targeted results such as compounds tested in specific cell lines with different IC50 values.</p><p id="p-21">An extensive ‘Structure Search’ interface is also available in NVIK. The user can query using SMILES, SDF and MOL formats. In addition, the users can also draw a compound in JSME browser that may be searched in NVIK.</p></div><div id="sec-13" class="subsection"><h4>2.2 Browsing interface</h4><p id="p-22">Data on NVIs can be browsed for physicochemical properties like molecular weight, XLogP, polar surface area (PSA), hydrogen bond donor (HBD), hydrogen bond acceptor (HBA) and the number of rotatable bonds (<a href="http://bioinfo.imtech.res.in/anshu/nipah/physico_chem.php">http://bioinfo.imtech.res.in/anshu/nipah/physico_chem.php</a>). The database can also be browsed from major fields as shown in <a id="xref-fig-1-2" class="xref-fig" href="#F1">Figure 1</a>.</p></div></div><div id="sec-14" class="subsection"><h3>3 Tools used for compound analysis and clustering</h3><p id="p-23">Near neighbours (NNs) in NVIK are identified using NNeib (version 5.12.0) (<a href="https://docs.chemaxon.com/display/docs/Jarvis-Patrick+clustering">https://docs.chemaxon.com/display/docs/Jarvis-Patrick+clustering</a>). The clusters of NVIs have been obtained using Jarp (version 6.0.2) (<a href="https://docs.chemaxon.com/display/docs/Jarvis-Patrick+clustering">https://docs.chemaxon.com/display/docs/Jarvis-Patrick+clustering</a>). which is based on the dissimilarity threshold (1-Tanimoto coefficient). A threshold of 0.15 is used as the dissimilarity coefficient. A total of 1875 descriptors were calculated using PaDel software [<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>]. To prioritize drug-like compounds, Drulito (<a href="http://www.niper.gov.in/pi_dev_tools/DruLiToWeb/DruLiTo_index.html">http://www.niper.gov.in/pi_dev_tools/DruLiToWeb/DruLiTo_index.html</a>) and PAINS filters were applied. Clustering is also performed with FDA approved compounds and the results are reported with known side-effects and predicted rat acute toxicity of NVIs similar to FDA approved compounds (<a href="http://bioinfo.imtech.res.in/anshu/nipah/fda_app.php">http://bioinfo.imtech.res.in/anshu/nipah/fda_app.php</a>).</p></div></div><div class="section" id="sec-15"><h2 class="">Visualization tools</h2><p id="p-24">We have customized a CIRCOS [<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>] (<a href="http://circos.ca/">http://circos.ca/</a>) in one of our earlier studies on phytomolecules in mycobacteria [<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>]. We utilized a similar approach to represent the relationship among physicochemical properties of NVIs. In customized CIRCOS, 98 inhibitors are defined with a band having a width of 1000. This baseline is used to represent cyclic and aliphatic compounds. Appropriate modifications were then applied to generate further histogram files. To view the the compounds clusters, a compound network diagram (CND) was made using Cytoscape (<a href="http://www.cytoscape.org/">http://www.cytoscape.org/</a>).</p></div><div class="section" id="sec-16"><h2 class="">Results &amp; Discussion</h2><div id="sec-17" class="subsection"><h3>NVIK statistics</h3><p id="p-25">At present, NVIK has 182 entries. The focus of the study was to evaluate small molecule inhibitors which were 125 entries as the rest 57 were either peptide or did not have complete information. Of these 125 entries, 98 are unique nipah inhibitors as for a few compounds more than one assay has been curated from the literature. Of these, EC50/IC50 values could be obtained for 70 compounds and structures are available for all 98 inhibitors. The EC50/IC50 values range from 0.25 nM to 7562710 nM for 182 entries and 0.47 nM to 7562710 nM for 125 small molecule entries. Some of these compounds are available in DrugBank and are predicted to have anti-nipah properties. The NVIK compounds are also mapped to Pubchem/Chemspider IDs wherever possible.</p></div><div id="sec-18" class="subsection"><h3>Physicochemical properties and diversity in NVIKs</h3><p id="p-26">The overall distribution of important physicochemical properties of NVIs is depicted in <a id="xref-fig-2-1" class="xref-fig" href="#F2">Figure 2</a>. It can be observed that most compounds in NVIK are cyclic in nature. Clustering of 98 NVIs resulted in 90 clusters of which 84 clusters (93.3% of NVIs) were singletons while remaining 14 clusters (15.5% of NVIs) were non-singletons. This illustrates that the NVIK library is chemically diverse. These clusters are represented as compound network diagrams made using Cytoscape. (<a href="http://bioinfo.imtech.res.in/anshu/nipah/circos.php">http://bioinfo.imtech.res.in/anshu/nipah/circos.php</a>) and the clusters are also reported in CIRCOS.</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="CIRCOS Plot illustrating the overall distribution of chemical and physicochemical properties of 98 NVIK small molecules. The diagram consists of 8 rings with the outermost ring categorizing the compounds as aliphatic or cyclic depending on their chemical nature. The subsequent rings illustrate the six graphs of calculated physicochemical properties. All compounds in the diagram are arranged in the increasing order of their molecular weight. The innermost ring represents the near neighbour network of NVIK compounds. Example of GS-441524 and GS-441524 (&#x201C;NUC&#x201D;) is shown. While the two compounds are structurally similar, the latter displays a better antiviral activity. It may be suspected that the slightest differences in the structure are responsible for this effect thus enabling derivation of pharmacophore features." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1635326302" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;span xmlns=&quot;http://www.w3.org/1999/xhtml&quot; class=&quot;caption-title&quot;&gt;CIRCOS Plot illustrating the overall distribution of chemical and physicochemical properties of 98 NVIK small molecules.&lt;/span&gt; The diagram consists of 8 rings with the outermost ring categorizing the compounds as aliphatic or cyclic depending on their chemical nature. The subsequent rings illustrate the six graphs of calculated physicochemical properties. All compounds in the diagram are arranged in the increasing order of their molecular weight. The innermost ring represents the near neighbour network of NVIK compounds. Example of GS-441524 and GS-441524 (&#x201C;NUC&#x201D;) is shown. While the two compounds are structurally similar, the latter displays a better antiviral activity. It may be suspected that the slightest differences in the structure are responsible for this effect thus enabling derivation of pharmacophore features.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 2:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F2.medium.gif" width="440" height="209"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 2:" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F2.medium.gif" width="440" height="209"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2:" data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 2:</span> <span class="caption-title">CIRCOS Plot illustrating the overall distribution of chemical and physicochemical properties of 98 NVIK small molecules.</span><p id="p-27" class="first-child">The diagram consists of 8 rings with the outermost ring categorizing the compounds as aliphatic or cyclic depending on their chemical nature. The subsequent rings illustrate the six graphs of calculated physicochemical properties. All compounds in the diagram are arranged in the increasing order of their molecular weight. The innermost ring represents the near neighbour network of NVIK compounds. Example of GS-441524 and GS-441524 (“NUC”) is shown. While the two compounds are structurally similar, the latter displays a better antiviral activity. It may be suspected that the slightest differences in the structure are responsible for this effect thus enabling derivation of pharmacophore features.</p><div class="sb-div caption-clear"></div></div></div><p id="p-28">The innermost graph in <a id="xref-fig-2-2" class="xref-fig" href="#F2">Figure 2</a> represents the near neighbours among NVIs. An intriguing observation is that compounds with different molecular weight range are near neighbours. For example, GS-441524 (531.202 g/mol) is a near neighbour of GS-441524 (“NUC”) (291.267 g/mol). There may be common structural features in these compounds that are responsible for their activity against NiV (as highlighted). Therefore, this approach is useful in identifying potential pharmacophore features that are important in contributing to the antiviral properties of these compounds.</p></div><div id="sec-19" class="subsection"><h3>Physicochemical property distribution of NVIs, FDA approved compounds and Antivirals</h3><p id="p-29">Comparison of NVIs is done with FDA approved compounds (2346) and antivirals obtained from Enamine library (4644). Enamine is a library of nucleoside like compounds (<a href="https://enamine.net/hit-finding/focused-libraries/view-all/antiviral-library">https://enamine.net/hit-finding/focused-libraries/view-all/antiviral-library</a>). On the basis of physicochemical properties as suggested by Lipinski and Veber [<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>] it is observed that for the majority of NVIs, the distribution of all the six properties is similar to FDA approved drugs and also in some cases with Enamine compounds (<a id="xref-fig-3-1" class="xref-fig" href="#F3">Figure 3</a>). Drugs with good oral availability, demonstrate TopoPSA ≤ 140 Å2 and number of rotatable bonds ≤ 10.</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Physicochemical distribution of NVIs with respect to FDA approved and enamine compounds based on six properties. These properties were studied using the PaDel software. It can be observed that most NVIs have properties which overlap with FDA approved drugs or antiviral compounds." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1635326302" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;span xmlns=&quot;http://www.w3.org/1999/xhtml&quot; class=&quot;caption-title&quot;&gt;Physicochemical distribution of NVIs with respect to FDA approved and enamine compounds based on six properties.&lt;/span&gt; These properties were studied using the PaDel software. It can be observed that most NVIs have properties which overlap with FDA approved drugs or antiviral compounds.&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 3:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F3.medium.gif" width="440" height="416"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 3:" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F3.medium.gif" width="440" height="416"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3:" data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 3:</span> <span class="caption-title">Physicochemical distribution of NVIs with respect to FDA approved and enamine compounds based on six properties.</span><p id="p-30" class="first-child">These properties were studied using the PaDel software. It can be observed that most NVIs have properties which overlap with FDA approved drugs or antiviral compounds.</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-20" class="subsection"><h3>Structural similarity of NVIs with existing drugs</h3><p id="p-31">In total, there are 34 NVIs similar to 76 FDA approved drugsf. For e.g, 5’–deoxy-5’-methylthioadenosine (NVIC0097) has shown structural similarity against four FDA molecules, namely, Adenosine (a neurotransmitter), Vidarabine (active antiviral against herpes, vaccinia &amp; varicella zoster virus), Fludarabine (a chemotherapy drug) and Ademetionine (used in the treatment of chronic liver diseases). In addition, side effects and predicted rat toxicity as reported in DrugBank is also listed for FDA approved compounds similar to NVIs (<a href="http://bioinfo.imtech.res.in/anshu/nipah/fda_app.php">http://bioinfo.imtech.res.in/anshu/nipah/fda_app.php</a>). This can aid in prioritization of NVIs with a potential safe profile as opposed to the ones which have reported side effects.</p></div><div id="sec-21" class="subsection"><h3>Drug-likeness of NVIs</h3><p id="p-32">In order to prioritize druglike NVIs, DruLito is used which screens all compounds based on eight filters, namely, Lipinski’s rule, MDDR-like rule, Veber rule, Ghose filter, BBB rule, CMC-50 like rule, weighted and unweighted Quantitative Estimate of Drug-likeness [<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">34</a>][<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">35</a>][<a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">36</a>]. As can be seen from <a id="xref-fig-4-1" class="xref-fig" href="#F4">Figure 4</a> only two of 91 compounds passed all filters other than CMC filter.</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Drug-likeness study of NVIK compounds. (A) Compound distribution graph of 91 NVIs that can be filtered by DruLiTo (Drug-likeness Tool) filter with 2 compounds passing seven filters. More than half of the compounds pass at least four DruLito filters. (B) Structure of NVIK compounds crossing seven filters of DruLiTo: NVIC0009-N-(Cyclopropylmethyl)-1-ethyl-6-fluoro-4-oxo-1,4-N-(4-Chlorobenzyl)-1-ethyl-4-oxo-7- (trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and NVIC0040 &#x2013; 848-0115" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1635326302" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Drug-likeness study of NVIK compounds.&lt;/span&gt; (A) Compound distribution graph of 91 NVIs that can be filtered by DruLiTo (Drug-likeness Tool) filter with 2 compounds passing seven filters. More than half of the compounds pass at least four DruLito filters. (B) Structure of NVIK compounds crossing seven filters of DruLiTo: &lt;strong&gt;NVIC0009&lt;/strong&gt;-N-(Cyclopropylmethyl)-1-ethyl-6-fluoro-4-oxo-1,4-N-(4-Chlorobenzyl)-1-ethyl-4-oxo-7- (trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and &lt;strong&gt;NVIC0040&lt;/strong&gt; &#x2013; 848-0115&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 4:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F4.medium.gif" width="427" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 4:" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F4.medium.gif" width="427" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4:" data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/12/2020.03.12.977918/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 4:</span> <span class="caption-title">Drug-likeness study of NVIK compounds.</span><p id="p-33" class="first-child">(A) Compound distribution graph of 91 NVIs that can be filtered by DruLiTo (Drug-likeness Tool) filter with 2 compounds passing seven filters. More than half of the compounds pass at least four DruLito filters. (B) Structure of NVIK compounds crossing seven filters of DruLiTo: <strong>NVIC0009</strong>-N-(Cyclopropylmethyl)-1-ethyl-6-fluoro-4-oxo-1,4-N-(4-Chlorobenzyl)-1-ethyl-4-oxo-7- (trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide and <strong>NVIC0040</strong> – 848-0115</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-22" class="subsection"><h3>Combined evidence approach for prioritizing NVIs</h3><p id="p-34">In order to prioritize NVIs for further studies, we performed an independent evaluation of the compounds based on the robustness of the assays that were used to identify them. Based on this analysis, we prioritised 11 NVIs. Further analysis of these NVIs also indicated that they have physicochemical descriptor values which are closer to existing drug like FDA approved compounds. Our analysis of FDA approved compounds for several physicochemical parameters namely molecular weight, number of hydrogen bond donors, number of hydrogen bond acceptors, number of rotatable bonds, XlogP and topological polar surface area revealed that most prioritized NVIs have drug like features. As can be seen from <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">Table 2</a>, NVIC0025, NVIC0032 and NVIC0048 passed 6 DruLito filters and were accepted in FAF drugs analysis. Of the three compounds shortlisted NVIC0048 displayed a high degree of overlap with all six physicochemical parameter ranges. However NVIC0032 (9167 (2,2,2-trifluoro-N-[3-(N-naphthylcarbamoyl)(4,5,6,7-tetrahydrobenzo[β]thiophen-2-yl)]acetamide) exhibits better activity among the three and has considerable overlap with the physicochemical properties of FDA approved drugs. The scope of the current study was to perform a systematic evaluation of physicochemical properties of NVIs with respect to FDA approved drugs and antiviral libraries, understand the diversity of chemical scaffolds and correlate these computed properties with the experimentally reported bioactivity datasets for proposing a list of prioritized candidates. In order to simplify data access and further enhancement of data libraries, a web-based platform is designed for reporting new compounds, further analysis and prioritization of potential NVIs.</p><div id="T2" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/1198479/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup"><a href="/highwire/markup/1198479/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/1198479" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div></div><div class="table-caption"><span class="table-label">Table 2:</span> <p id="p-35" class="first-child">List of prioritized NVIs along with their biological activity, drug likeness profile and structural similarity to antivirals / FDA approved small molecular libraries. Most compounds were found to be dissimilar to FDA approved small molecule with the exception of bortezomib (NVIC0027) and chloroquine (NVIC0048).</p><div class="sb-div caption-clear"></div></div></div></div><div id="sec-23" class="subsection"><h3>Availability and requirements</h3><p id="p-36">NVIK is freely accessible at: <a href="http://bioinfo.imtech.res.in/anshu/nipah/">http://bioinfo.imtech.res.in/anshu/nipah/</a>. To access all the features of NVIK to its optimum level, JavaScript and Java Runtime Environment (JRE) plugin must be enabled.</p></div></div><div class="section" id="sec-24"><h2 class="">Author’s Contribution</h2><p id="p-52">NK, KT compiled data from the literature. NK, KT, PRP an AU curated the data and updated the field wherever data was incomplete. NK and PRP curated chemical structures. KT, KK and RK developed the database, web-based tools and the interface of NVIK with inputs from NK and AB. NK performed compound analysis. TS and NK plot visualization plots, CIRCOS and CND. EC performed assay robustness analysis and ranking, NK, KT, PRP, AU and AB drafted the manuscript. VS and AB conceived and designed the project and refined the manuscript. VS and AB defined the SOP for data collection and also the data structure. The manuscript has been read and approved by all authors.</p></div><div class="section ack" id="ack-1"><h2 class="">Acknowledgements</h2><p id="p-53">TS acknowledges fellowship from DST INSPIRE and RK acknowledges fellowship from CSIR.</p></div><div class="section glossary"><h2 class="">Abbreviations</h2><dl id="def-list-1"><dt id="def-item-1">FDA<span class="def-item-dt-sep"></span></dt><dd>Food and Drug Administration,<span class="def-item-dd-sep"></span></dd><dt id="def-item-2">NVIs<span class="def-item-dt-sep"></span></dt><dd>Nipah Virus Inhibitors,<span class="def-item-dd-sep"></span></dd><dt id="def-item-3">Niv<span class="def-item-dt-sep"></span></dt><dd>Nipah Virus,<span class="def-item-dd-sep"></span></dd><dt id="def-item-4">WHO<span class="def-item-dt-sep"></span></dt><dd>World Health Organization,<span class="def-item-dd-sep"></span></dd><dt id="def-item-5">R&amp;D<span class="def-item-dt-sep"></span></dt><dd>Research and Development,<span class="def-item-dd-sep"></span></dd><dt id="def-item-6">PAINS<span class="def-item-dt-sep"></span></dt><dd>Pan-assay interference compounds,<span class="def-item-dd-sep"></span></dd><dt id="def-item-7">IC50<span class="def-item-dt-sep"></span></dt><dd>Half maximal inhibitory concentration,<span class="def-item-dd-sep"></span></dd><dt id="def-item-8">EC50<span class="def-item-dt-sep"></span></dt><dd>half-maximal effective concentration,<span class="def-item-dd-sep"></span></dd><dt id="def-item-9">NVIK<span class="def-item-dt-sep"></span></dt><dd>Nipah Virus Inhibitor Knowledgebase,<span class="def-item-dd-sep"></span></dd><dt id="def-item-10">NVIC<span class="def-item-dt-sep"></span></dt><dd>Nipah Virus Inhibitor Collection,<span class="def-item-dd-sep"></span></dd><dt id="def-item-11">LAMP<span class="def-item-dt-sep"></span></dt><dd>Linux-Apache-Mysql-PHP,<span class="def-item-dd-sep"></span></dd><dt id="def-item-12">SMILES: SDF<span class="def-item-dt-sep"></span></dt><dd>structure data file,<span class="def-item-dd-sep"></span></dd><dt id="def-item-13">Nneib<span class="def-item-dt-sep"></span></dt><dd>Near Neighbour,<span class="def-item-dd-sep"></span></dd><dt id="def-item-14">TopoPSA<span class="def-item-dt-sep"></span></dt><dd>topological polar surface area,<span class="def-item-dd-sep"></span></dd><dt id="def-item-15">NADH<span class="def-item-dt-sep"></span></dt><dd>Nicotinamide adenine dinucleotide.</dd></dl></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">[1].</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference [1] in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.1" data-doi="10.1016/S1286-4579(01)01381-8"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">LF</span></span>, <span class="cit-auth"><span class="cit-name-surname">Harcourt</span>  <span class="cit-name-given-names">BH</span></span>, <span class="cit-auth"><span class="cit-name-surname">Yu</span>  <span class="cit-name-given-names">M</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Molecular biology of Hendra and Nipah viruses</span>. <abbr class="cit-jnl-abbrev">Microbes Infect</abbr>. <span class="cit-pub-date">2001</span>; <span class="cit-vol">3</span>: <span class="cit-fpage">279</span>–<span class="cit-lpage">287</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMicrobes%2Band%2Binfection%2B%252F%2BInstitut%2BPasteur%26rft.stitle%253DMicrobes%2BInfect%26rft.aulast%253DWang%26rft.auinit1%253DL.%26rft.volume%253D3%26rft.issue%253D4%26rft.spage%253D279%26rft.epage%253D287%26rft.atitle%253DMolecular%2Bbiology%2Bof%2BHendra%2Band%2BNipah%2Bviruses.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1286-4579%252801%252901381-8%26rft_id%253Dinfo%253Apmid%252F11334745%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S1286-4579(01)01381-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11334745&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[2].</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference [2] in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.2" data-doi="10.1128/JCM.01875-17"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ang</span>  <span class="cit-name-given-names">BSP</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lim</span>  <span class="cit-name-given-names">TCC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wang</span>  <span class="cit-name-given-names">L.</span></span> <span class="cit-article-title">Nipah virus infection</span>. <abbr class="cit-jnl-abbrev">J Clin Microbiol</abbr> <span class="cit-pub-date">2018</span>; <span class="cit-vol">56</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi: </span><span class="cit-pub-id cit-pub-id-doi">10.1128/JCM.01875-17</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BClin%2BMicrobiol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJCM.01875-17%26rft_id%253Dinfo%253Apmid%252F29643201%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNtIjtzOjU6InJlc2lkIjtzOjE0OiI1Ni82L2UwMTg3NS0xNyI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[3].</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference [3] in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.3" data-doi="10.4269/ajtmh.2011.10-0567"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Halpin</span>  <span class="cit-name-given-names">K</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hyatt</span>  <span class="cit-name-given-names">AD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Fogarty</span>  <span class="cit-name-given-names">R</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Pteropid bats are confirmed as the reservoir hosts of henipaviruses: A comprehensive experimental study of virus transmission</span>. <abbr class="cit-jnl-abbrev">Am J Trop Med Hyg</abbr> <span class="cit-pub-date">2011</span>; <span class="cit-vol">85</span>: <span class="cit-fpage">946</span>–<span class="cit-lpage">951</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BAmerican%2BJournal%2Bof%2BTropical%2BMedicine%2Band%2BHygiene%26rft.stitle%253DAm%2BJ%2BTrop%2BMed%2BHyg%26rft.aulast%253DHalpin%26rft.auinit1%253DK.%26rft.volume%253D85%26rft.issue%253D5%26rft.spage%253D946%26rft.epage%253D951%26rft.atitle%253DPteropid%2BBats%2Bare%2BConfirmed%2Bas%2Bthe%2BReservoir%2BHosts%2Bof%2BHenipaviruses%253A%2BA%2BComprehensive%2BExperimental%2BStudy%2Bof%2BVirus%2BTransmission%26rft_id%253Dinfo%253Adoi%252F10.4269%252Fajtmh.2011.10-0567%26rft_id%253Dinfo%253Apmid%252F22049055%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoidHJvcG1lZCI7czo1OiJyZXNpZCI7czo4OiI4NS81Lzk0NiI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[4].</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference [4] in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.4"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">Centers for Disease Control and Prevention (CDC). Outbreak of Hendra-like virus--Malaysia and Singapore, 1998-1999</span>. <abbr class="cit-jnl-abbrev">MMWR Morb Mortal Wkly Rep</abbr> <span class="cit-pub-date">1999</span>; <span class="cit-vol">48</span>: <span class="cit-fpage">265</span>–<span class="cit-lpage">9</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMMWR.%2B%2BMorbidity%2Band%2Bmortality%2Bweekly%2Breport%26rft.stitle%253DMMWR%2BMorb%2BMortal%2BWkly%2BRep%26rft.volume%253D48%26rft.issue%253D13%26rft.spage%253D265%26rft.epage%253D269%26rft.atitle%253DOutbreak%2Bof%2BHendra-like%2Bvirus--Malaysia%2Band%2BSingapore%252C%2B1998-1999.%26rft_id%253Dinfo%253Apmid%252F10227800%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10227800&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[5].</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference [5] in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.5" data-doi="10.1086/315457"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Parashar</span>  <span class="cit-name-given-names">UD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sunn</span>  <span class="cit-name-given-names">LM</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ong</span>  <span class="cit-name-given-names">F</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Case□Control Study of Risk Factors for Human Infection with a New Zoonotic Paramyxovirus, Nipah Virus, during a 1998–1999 Outbreak of Severe Encephalitis in Malaysia</span>. <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-pub-date">2000</span>; <span class="cit-vol">181</span>: <span class="cit-fpage">1755</span>–<span class="cit-lpage">1759</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F315457%26rft_id%253Dinfo%253Apmid%252F10823779%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/315457&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=10823779&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000087353700032&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[6].</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference [6] in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.6" data-doi="10.3201/eid1012.040701"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hsu</span>  <span class="cit-name-given-names">VP</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hossain</span>  <span class="cit-name-given-names">MJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Parashar</span>  <span class="cit-name-given-names">UD</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Nipah virus encephalitis reemergence, Bangladesh</span>. <abbr class="cit-jnl-abbrev">Emerg Infect Dis</abbr> <span class="cit-pub-date">2004</span>; <span class="cit-vol">10</span>: <span class="cit-fpage">2082</span>–<span class="cit-lpage">2087</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEmerging%2Binfectious%2Bdiseases%26rft.stitle%253DEmerg%2BInfect%2BDis%26rft.aulast%253DHsu%26rft.auinit1%253DV.%2BP.%26rft.volume%253D10%26rft.issue%253D12%26rft.spage%253D2082%26rft.epage%253D2087%26rft.atitle%253DNipah%2Bvirus%2Bencephalitis%2Breemergence%252C%2BBangladesh.%26rft_id%253Dinfo%253Adoi%252F10.3201%252Feid1012.040701%26rft_id%253Dinfo%253Apmid%252F15663842%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3201/eid1012.040701&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=15663842&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000225528000004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[7].</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference [7] in text" id="ref-7">↵</a><div class="cit ref-cit ref-web" id="cit-2020.03.12.977918v1.7"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">Nipah Virus Distribution Map | Nipah Virus (NiV) | CDC</span>. <a href="https://www.cdc.gov/vhf/nipah/outbreaks/distribution-map.html">https://www.cdc.gov/vhf/nipah/outbreaks/distribution-map.html</a> (<span class="cit-date-in-citation">accessed 11 Nov2019</span>).</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">[8].</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference [8] in text" id="ref-8">↵</a><div class="cit ref-cit ref-web" id="cit-2020.03.12.977918v1.8"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">World Health Organization, Nipah virus outbreaks in the WHO South-East Asia Region</span>. <a href="http://www.searo.who.int/entity/emerging_diseases/links/nipah_virus_outbreaks_sear/en/">http://www.searo.who.int/entity/emerging_diseases/links/nipah_virus_outbreaks_sear/en/</a> (<span class="cit-date-in-citation">accessed 11 Nov2019</span>).</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">[9].</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference [9] in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.9" data-doi="10.3201/eid1202.051247"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chadha</span>  <span class="cit-name-given-names">MS</span></span>, <span class="cit-auth"><span class="cit-name-surname">Comer</span>  <span class="cit-name-given-names">JA</span></span>, <span class="cit-auth"><span class="cit-name-surname">Lowe</span>  <span class="cit-name-given-names">L</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Nipah virus-associated encephalitis outbreak, Siliguri, India</span>. <abbr class="cit-jnl-abbrev">Emerg Infect Dis</abbr> <span class="cit-pub-date">2006</span>; <span class="cit-vol">12</span>: <span class="cit-fpage">235</span>–<span class="cit-lpage">240</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEmerging%2Binfectious%2Bdiseases%26rft.stitle%253DEmerg%2BInfect%2BDis%26rft.aulast%253DChadha%26rft.auinit1%253DM.%2BS.%26rft.volume%253D12%26rft.issue%253D2%26rft.spage%253D235%26rft.epage%253D240%26rft.atitle%253DNipah%2Bvirus-associated%2Bencephalitis%2Boutbreak%252C%2BSiliguri%252C%2BIndia.%26rft_id%253Dinfo%253Adoi%252F10.3201%252Feid1202.051247%26rft_id%253Dinfo%253Apmid%252F16494748%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3201/eid1202.051247&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16494748&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000235287400009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[10].</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference [10] in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.10" data-doi="10.1086/647951"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Luby</span>  <span class="cit-name-given-names">SP</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gurley</span>  <span class="cit-name-given-names">ES</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hossain</span>  <span class="cit-name-given-names">MJ</span></span>. <span class="cit-article-title">Transmission of Human Infection with Nipah Virus</span>. <abbr class="cit-jnl-abbrev">Clin Infect Dis</abbr> <span class="cit-pub-date">2009</span>; <span class="cit-vol">49</span>: <span class="cit-fpage">1743</span>–<span class="cit-lpage">1748</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DClinical%2BInfectious%2BDiseases%26rft.stitle%253DClinical%2BInfectious%2BDiseases%26rft.aulast%253DLuby%26rft.auinit1%253DS.%2BP.%26rft.volume%253D49%26rft.issue%253D11%26rft.spage%253D1743%26rft.epage%253D1748%26rft.atitle%253DTransmission%2Bof%2Bhuman%2Binfection%2Bwith%2BNipah%2Bvirus.%26rft_id%253Dinfo%253Adoi%252F10.1086%252F647951%26rft_id%253Dinfo%253Apmid%252F19886791%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/647951&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19886791&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[11].</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference [11] in text" id="ref-11">↵</a><div class="cit ref-cit ref-web" id="cit-2020.03.12.977918v1.11"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">WHO | Nipah virus – India</span>. <a href="https://www.who.int/csr/don/07-august-2018-nipah-virus-india/en/">https://www.who.int/csr/don/07-august-2018-nipah-virus-india/en/</a> (<span class="cit-date-in-citation">accessed 11 Nov2019</span>).</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">[12].</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference [12] in text" id="ref-12">↵</a><div class="cit ref-cit ref-web" id="cit-2020.03.12.977918v1.12"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">23-year-old student infected with Nipah virus, confirms Kerala govt - The Hindu</span>. <a href="https://www.thehindu.com/news/national/kerala/one-confirmed-case-of-nipah-in-kochi/article27437677.ece">https://www.thehindu.com/news/national/kerala/one-confirmed-case-of-nipah-in-kochi/article27437677.ece</a> (<span class="cit-date-in-citation">accessed 11 Nov2019</span>).</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">[13].</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference [13] in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.13" data-doi="10.1160/TH09-05-0310"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Maisner</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Neufeld</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weingartl</span>  <span class="cit-name-given-names">H.</span></span> <span class="cit-article-title">Organ- and endotheliotropism of Nipah virus infections in vivo and in vitro</span>. <abbr class="cit-jnl-abbrev">Thromb. Haemost</abbr>. <span class="cit-pub-date">2009</span>; <span class="cit-vol">102</span>: <span class="cit-fpage">1014</span>–<span class="cit-lpage">1023</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThrombosis%2Band%2Bhaemostasis%26rft.stitle%253DThromb%2BHaemost%26rft.aulast%253DMaisner%26rft.auinit1%253DA.%26rft.volume%253D102%26rft.issue%253D6%26rft.spage%253D1014%26rft.epage%253D1023%26rft.atitle%253DOrgan-%2Band%2Bendotheliotropism%2Bof%2BNipah%2Bvirus%2Binfections%2Bin%2Bvivo%2Band%2Bin%2Bvitro.%26rft_id%253Dinfo%253Adoi%252F10.1160%252FTH09-05-0310%26rft_id%253Dinfo%253Apmid%252F19967130%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1160/TH09-05-0310&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19967130&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[14].</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference [14] in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.14" data-doi="10.1016/j.virol.2008.02.019"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Diederich</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Thiel</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"><span class="cit-name-surname">Maisner</span>  <span class="cit-name-given-names">A.</span></span> <span class="cit-article-title">Role of endocytosis and cathepsin-mediated activation in Nipah virus entry</span>. <abbr class="cit-jnl-abbrev">Virology</abbr> <span class="cit-pub-date">2008</span>; <span class="cit-vol">375</span>: <span class="cit-fpage">391</span>–<span class="cit-lpage">400</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirology%26rft.stitle%253DVirology%26rft.aulast%253DDiederich%26rft.auinit1%253DS.%26rft.volume%253D375%26rft.issue%253D2%26rft.spage%253D391%26rft.epage%253D400%26rft.atitle%253DRole%2Bof%2Bendocytosis%2Band%2Bcathepsin-mediated%2Bactivation%2Bin%2BNipah%2Bvirus%2Bentry.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.virol.2008.02.019%26rft_id%253Dinfo%253Apmid%252F18342904%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.virol.2008.02.019&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=18342904&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000256106200009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[15].</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference [15] in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.15" data-doi="10.1128/JVI.02599-08"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kulkarni</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Volchkova</span>  <span class="cit-name-given-names">V</span></span>, <span class="cit-auth"><span class="cit-name-surname">Basler</span>  <span class="cit-name-given-names">CF</span></span>, <span class="cit-auth"><span class="cit-name-surname">Palese</span>  <span class="cit-name-given-names">P</span></span>, <span class="cit-auth"><span class="cit-name-surname">Volchkov</span>  <span class="cit-name-given-names">VE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Shaw</span>  <span class="cit-name-given-names">ML</span></span>. <span class="cit-article-title">Nipah Virus Edits Its P Gene at High Frequency To Express the V and W Proteins</span>. <abbr class="cit-jnl-abbrev">J Virol</abbr> <span class="cit-pub-date">2009</span>; <span class="cit-vol">83</span>: <span class="cit-fpage">3982</span>–<span class="cit-lpage">3987</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.02599-08%26rft_id%253Dinfo%253Apmid%252F19211754%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjk6IjgzLzgvMzk4MiI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[16].</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference [16] in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.16" data-doi="10.1016/S0166-3542(02)00204-8"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lam</span>  <span class="cit-name-given-names">S-K.</span></span> <span class="cit-article-title">Nipah virus--a potential agent of bioterrorism?</span> <abbr class="cit-jnl-abbrev">Antiviral Res</abbr> <span class="cit-pub-date">2003</span>; <span class="cit-vol">57</span>: <span class="cit-fpage">113</span>–<span class="cit-lpage">9</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntiviral%2Bresearch%26rft.stitle%253DAntiviral%2BRes%26rft.aulast%253DLam%26rft.auinit1%253DS.%2BK.%26rft.volume%253D57%26rft.issue%253D1-2%26rft.spage%253D113%26rft.epage%253D119%26rft.atitle%253DNipah%2Bvirus--a%2Bpotential%2Bagent%2Bof%2Bbioterrorism%253F%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0166-3542%252802%252900204-8%26rft_id%253Dinfo%253Apmid%252F12615307%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0166-3542(02)00204-8&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12615307&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000181705800012&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[17].</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference [17] in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.17" data-doi="10.1128/JVI.78.18.10211.2004"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Snell</span>  <span class="cit-name-given-names">NJC.</span></span> <span class="cit-article-title">Ribavirin Therapy for Nipah Virus Infection</span>. <abbr class="cit-jnl-abbrev">J Virol</abbr> <span class="cit-pub-date">2004</span>; <span class="cit-vol">78</span>: <span class="cit-fpage">10211</span>–<span class="cit-lpage">10211</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BVirology%26rft.stitle%253DJ.%2BVirol.%26rft.aulast%253DSnell%26rft.auinit1%253DN.%2BJ.%2BC.%26rft.volume%253D78%26rft.issue%253D18%26rft.spage%253D10211%26rft.epage%253D10211%26rft.atitle%253DRibavirin%2BTherapy%2Bfor%2BNipah%2BVirus%2BInfection%26rft_id%253Dinfo%253Adoi%252F10.1128%252FJVI.78.18.10211.2004%26rft_id%253Dinfo%253Apmid%252F15331756%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoianZpIjtzOjU6InJlc2lkIjtzOjExOiI3OC8xOC8xMDIxMSI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[18].</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference [18] in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.18" data-doi="10.1002/ana.1062"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Chong</span>  <span class="cit-name-given-names">HT</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kamarulzaman</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Tan</span>  <span class="cit-name-given-names">CT</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Treatment of acute Nipah encephalitis with ribavirin</span>. <abbr class="cit-jnl-abbrev">Ann Neurol</abbr> <span class="cit-pub-date">2001</span>; <span class="cit-vol">49</span>: <span class="cit-fpage">810</span>–<span class="cit-lpage">813</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAnnals%2Bof%2Bneurology%26rft.stitle%253DAnn%2BNeurol%26rft.aulast%253DChong%26rft.auinit1%253DH.%2BT.%26rft.volume%253D49%26rft.issue%253D6%26rft.spage%253D810%26rft.epage%253D813%26rft.atitle%253DTreatment%2Bof%2Bacute%2BNipah%2Bencephalitis%2Bwith%2Bribavirin.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fana.1062%26rft_id%253Dinfo%253Apmid%252F11409437%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/ana.1062&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11409437&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000169091400021&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[19].</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference [19] in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.19" data-doi="10.1128/AAC.50.5.1768-1772.2006"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Georges-Courbot</span>  <span class="cit-name-given-names">MC</span></span>, <span class="cit-auth"><span class="cit-name-surname">Contamin</span>  <span class="cit-name-given-names">H</span></span>, <span class="cit-auth"><span class="cit-name-surname">Faure</span>  <span class="cit-name-given-names">C</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection</span>. <abbr class="cit-jnl-abbrev">Antimicrob Agents Chemother</abbr> <span class="cit-pub-date">2006</span>; <span class="cit-vol">50</span>: <span class="cit-fpage">1768</span>–<span class="cit-lpage">1772</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DGeorges-Courbot%26rft.auinit1%253DM.%2BC.%26rft.volume%253D50%26rft.issue%253D5%26rft.spage%253D1768%26rft.epage%253D1772%26rft.atitle%253DPoly%2528I%2529-Poly%2528C12U%2529%2Bbut%2BNot%2BRibavirin%2BPrevents%2BDeath%2Bin%2Ba%2BHamster%2BModel%2Bof%2BNipah%2BVirus%2BInfection%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.50.5.1768-1772.2006%26rft_id%253Dinfo%253Apmid%252F16641448%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjUwLzUvMTc2OCI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[20].</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference [20] in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.20" data-doi="10.1038/s41598-018-25780-3"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Dawes</span>  <span class="cit-name-given-names">BE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kalveram</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ikegami</span>  <span class="cit-name-given-names">T</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Favipiravir (T-705) protects against Nipah virus infection in the hamster model /631/326/22/1295 /631/326/596/1296 /13/106 /14/35 /38/77 /82/51 /96/63 article</span>. <abbr class="cit-jnl-abbrev">Sci Rep</abbr> <span class="cit-pub-date">2018</span>; <span class="cit-vol">8</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi: </span><span class="cit-pub-id cit-pub-id-doi">10.1038/s41598-018-25780-3</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DSci%2BRep%26rft.volume%253D8%26rft.spage%253D7604%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fs41598-018-25780-3%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/s41598-018-25780-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">[21].</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference [21] in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.21" data-doi="10.1126/scitranslmed.aau9242"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lo</span>  <span class="cit-name-given-names">MK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Feldmann</span>  <span class="cit-name-given-names">F</span></span>, <span class="cit-auth"><span class="cit-name-surname">Gary</span>  <span class="cit-name-given-names">JM</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Remdesivir (GS-5734) protects African green monkeys from Nipah virus challenge</span>. <abbr class="cit-jnl-abbrev">Sci Transl Med</abbr> <span class="cit-pub-date">2019</span>; <span class="cit-vol">11</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi: </span><span class="cit-pub-id cit-pub-id-doi">10.1126/scitranslmed.aau9242</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%2BTranslational%2BMedicine%26rft.stitle%253DSci%2BTransl%2BMed%26rft.aulast%253DLo%26rft.auinit1%253DM.%2BK.%26rft.volume%253D11%26rft.issue%253D494%26rft.spage%253Deaau9242%26rft.epage%253Deaau9242%26rft.atitle%253DRemdesivir%2B%2528GS-5734%2529%2Bprotects%2BAfrican%2Bgreen%2Bmonkeys%2Bfrom%2BNipah%2Bvirus%2Bchallenge%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscitranslmed.aau9242%26rft_id%253Dinfo%253Apmid%252F31142680%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTE6InNjaXRyYW5zbWVkIjtzOjU6InJlc2lkIjtzOjE1OiIxMS80OTQvZWFhdTkyNDIiO3M6NDoiYXRvbSI7czo0ODoiL2Jpb3J4aXYvZWFybHkvMjAyMC8wMy8xMi8yMDIwLjAzLjEyLjk3NzkxOC5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[22].</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference [22] in text" id="ref-22">↵</a><div class="cit ref-cit ref-web" id="cit-2020.03.12.977918v1.22"><div class="cit-metadata"><cite><span class="cit-auth cit-collab">Prioritizing diseases for research and development in emergency contexts</span>. <a href="https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-context">https://www.who.int/activities/prioritizing-diseases-for-research-and-development-in-emergency-context</a> (<span class="cit-date-in-citation">accessed 12 Nov2019</span>).</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">[23].</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference [23] in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.23" data-doi="10.1089/adt.2013.567"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Tigabu</span>  <span class="cit-name-given-names">B</span></span>, <span class="cit-auth"><span class="cit-name-surname">Rasmussen</span>  <span class="cit-name-given-names">L</span></span>, <span class="cit-auth"> <span class="cit-name-given-names">White EL et</span> <span class="cit-name-surname">al</span></span>. <span class="cit-article-title">A BSL-4 high-throughput screen identifies sulfonamide inhibitors of Nipah virus</span>. <abbr class="cit-jnl-abbrev">Assay Drug Dev Technol</abbr> <span class="cit-pub-date">2014</span>; <span class="cit-vol">12</span>: <span class="cit-fpage">155</span>–<span class="cit-lpage">161</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAssay%2BDrug%2BDev%2BTechnol%26rft.volume%253D12%26rft.spage%253D155%26rft_id%253Dinfo%253Adoi%252F10.1089%252Fadt.2013.567%26rft_id%253Dinfo%253Apmid%252F24735442%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1089/adt.2013.567&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24735442&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[24].</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference [24] in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.24" data-doi="10.3390/v11030229"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">García-Murria</span>  <span class="cit-name-given-names">MJ</span></span>, <span class="cit-auth"><span class="cit-name-surname">Expósito-Domínguez</span>  <span class="cit-name-given-names">N</span></span>, <span class="cit-auth"><span class="cit-name-surname">Duart</span>  <span class="cit-name-given-names">G</span></span>, <span class="cit-auth"><span class="cit-name-surname">Mingarro</span>  <span class="cit-name-given-names">I</span></span>, <span class="cit-auth"><span class="cit-name-surname">Martinez-Gil</span>  <span class="cit-name-given-names">L.</span></span> <span class="cit-article-title">A bimolecular multicellular complementation system for the detection of syncytium formation: A new methodology for the identification of Nipah virus entry inhibitors</span>. <abbr class="cit-jnl-abbrev">Viruses</abbr> <span class="cit-pub-date">2019</span>; <span class="cit-vol">11</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi: </span><span class="cit-pub-id cit-pub-id-doi">10.3390/v11030229</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DViruses%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv11030229%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/v11030229&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">[25].</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference [25] in text" id="ref-25">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.25"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Dang</span>  <span class="cit-name-given-names">H V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Chan</span>  <span class="cit-name-given-names">Y-P</span></span>, <span class="cit-auth"><span class="cit-name-surname">Park</span>  <span class="cit-name-given-names">Y-J</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections</span>. <abbr class="cit-jnl-abbrev">Nat Struct Mol Biol</abbr> <span class="cit-pub-date">2019</span>; <span class="cit-vol">26</span>: <span class="cit-fpage">980</span>–<span class="cit-lpage">987</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNat%2BStruct%2BMol%2BBiol%26rft.volume%253D26%26rft.spage%253D980%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">[26].</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference [26] in text" id="ref-26">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.26" data-doi="10.1093/nar/gkw857"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Zhang</span>  <span class="cit-name-given-names">Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Aevermann</span>  <span class="cit-name-given-names">BD</span></span>, <span class="cit-auth"><span class="cit-name-surname">Anderson</span>  <span class="cit-name-given-names">TK</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Influenza Research Database: An integrated bioinformatics resource for influenza virus research</span>. <abbr class="cit-jnl-abbrev">Nucleic Acids Res</abbr> <span class="cit-pub-date">2017</span>; <span class="cit-vol">45</span>: <span class="cit-fpage">D466</span>–<span class="cit-lpage">D474</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNucleic%2BAcids%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fnar%252Fgkw857%26rft_id%253Dinfo%253Apmid%252F27679478%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/nar/gkw857&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=27679478&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[27].</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference [27] in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.27" data-doi="10.1128/CMR.00102-15"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">De Clercq</span>  <span class="cit-name-given-names">E</span></span>, <span class="cit-auth"><span class="cit-name-surname">Li</span>  <span class="cit-name-given-names">G.</span></span> <span class="cit-article-title">Approved antiviral drugs over the past 50 years</span>. <abbr class="cit-jnl-abbrev">Clin. Microbiol. Rev</abbr>. <span class="cit-pub-date">2016</span>; <span class="cit-vol">29</span>: <span class="cit-fpage">695</span>–<span class="cit-lpage">747</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DClinical%2BMicrobiology%2BReviews%26rft.stitle%253DClin.%2BMicrobiol.%2BRev.%26rft.aulast%253DDe%2BClercq%26rft.auinit1%253DE.%26rft.volume%253D29%26rft.issue%253D3%26rft.spage%253D695%26rft.epage%253D747%26rft.atitle%253DApproved%2BAntiviral%2BDrugs%2Bover%2Bthe%2BPast%2B50%2BYears%26rft_id%253Dinfo%253Adoi%252F10.1128%252FCMR.00102-15%26rft_id%253Dinfo%253Apmid%252F27281742%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiY21yIjtzOjU6InJlc2lkIjtzOjg6IjI5LzMvNjk1IjtzOjQ6ImF0b20iO3M6NDg6Ii9iaW9yeGl2L2Vhcmx5LzIwMjAvMDMvMTIvMjAyMC4wMy4xMi45Nzc5MTguYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[28].</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference [28] in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.28" data-doi="10.3390/v4113209"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Pickett</span>  <span class="cit-name-given-names">BE</span></span>, <span class="cit-auth"><span class="cit-name-surname">Greer</span>  <span class="cit-name-given-names">DS</span></span>, <span class="cit-auth"><span class="cit-name-surname">Zhang</span>  <span class="cit-name-given-names">Y</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Virus pathogen Database and Analysis Resource (ViPR): A comprehensive bioinformatics Database and Analysis Resource for the Coronavirus research community</span>. <abbr class="cit-jnl-abbrev">Viruses</abbr> <span class="cit-pub-date">2012</span>; <span class="cit-vol">4</span>: <span class="cit-fpage">3209</span>–<span class="cit-lpage">3226</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DViruses%26rft.aulast%253DPickett%26rft.auinit1%253DB.%2BE.%26rft.volume%253D4%26rft.issue%253D11%26rft.spage%253D3209%26rft.epage%253D3226%26rft.atitle%253DVirus%2BPathogen%2BDatabase%2Band%2BAnalysis%2BResource%2B%2528ViPR%2529%253A%2B%2BA%2BComprehensive%2BBioinformatics%2BDatabase%2Band%2BAnalysis%2BResource%2Bfor%2Bthe%2BCoronavirus%2BResearch%2BCommunity.%26rft_id%253Dinfo%253Adoi%252F10.3390%252Fv4113209%26rft_id%253Dinfo%253Apmid%252F23202522%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3390/v4113209&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23202522&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[29].</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference [29] in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.29" data-doi="10.3389/fphar.2019.00071"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Rajput</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kumar</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kumar</span>  <span class="cit-name-given-names">M.</span></span> <span class="cit-article-title">Computational identification of inhibitors using QSAR approach against Nipah virus</span>. <abbr class="cit-jnl-abbrev">Front Pharmacol</abbr> <span class="cit-pub-date">2019</span>; <span class="cit-vol">10</span>.<span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span><span class="cit-pub-id-scheme">doi: </span><span class="cit-pub-id cit-pub-id-doi">10.3389/fphar.2019.00071</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DFront%2BPharmacol%26rft_id%253Dinfo%253Adoi%252F10.3389%252Ffphar.2019.00071%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3389/fphar.2019.00071&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">[30].</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference [30] in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.30" data-doi="10.1002/jcc.21707"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Yap</span>  <span class="cit-name-given-names">CW</span></span>. <span class="cit-article-title">PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints</span>. <abbr class="cit-jnl-abbrev">J Comput Chem</abbr> <span class="cit-pub-date">2011</span>; <span class="cit-vol">32</span>: <span class="cit-fpage">1466</span>–<span class="cit-lpage">1474</span></cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bcomputational%2Bchemistry%26rft.stitle%253DJ%2BComput%2BChem%26rft.aulast%253DYap%26rft.auinit1%253DC.%2BW.%26rft.volume%253D32%26rft.issue%253D7%26rft.spage%253D1466%26rft.epage%253D1474%26rft.atitle%253DPaDEL-descriptor%253A%2Ban%2Bopen%2Bsource%2Bsoftware%2Bto%2Bcalculate%2Bmolecular%2Bdescriptors%2Band%2Bfingerprints.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fjcc.21707%26rft_id%253Dinfo%253Apmid%252F21425294%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/jcc.21707&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21425294&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[31].</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference [31] in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.31" data-doi="10.1101/gr.092759.109"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Krzywinski</span>  <span class="cit-name-given-names">M</span></span>, <span class="cit-auth"><span class="cit-name-surname">Schein</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Birol</span>  <span class="cit-name-given-names">I</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Circos: An information aesthetic for comparative genomics</span>. <abbr class="cit-jnl-abbrev">Genome Res</abbr> <span class="cit-pub-date">2009</span>; <span class="cit-vol">19</span>: <span class="cit-fpage">1639</span>–<span class="cit-lpage">1645</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DGenome%2BRes%26rft_id%253Dinfo%253Adoi%252F10.1101%252Fgr.092759.109%26rft_id%253Dinfo%253Apmid%252F19541911%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiZ2Vub21lIjtzOjU6InJlc2lkIjtzOjk6IjE5LzkvMTYzOSI7czo0OiJhdG9tIjtzOjQ4OiIvYmlvcnhpdi9lYXJseS8yMDIwLzAzLzEyLzIwMjAuMDMuMTIuOTc3OTE4LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">[32].</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference [32] in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.32"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Sharma</span>  <span class="cit-name-given-names">A</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dutta</span>  <span class="cit-name-given-names">P</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sharma</span>  <span class="cit-name-given-names">M</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">BioPhytMol: a drug discovery community resource on anti-mycobacterial phytomolecules and plant extracts</span>. <abbr class="cit-jnl-abbrev">J Cheminform</abbr> <span class="cit-pub-date">2014</span>; <span class="cit-vol">6</span>: <span class="cit-fpage">46</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BCheminform%26rft.volume%253D6%26rft.spage%253D46%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">[33].</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference [33] in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.33" data-doi="10.1021/jm020017n"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Veber</span>  <span class="cit-name-given-names">DF</span></span>, <span class="cit-auth"><span class="cit-name-surname">Johnson</span>  <span class="cit-name-given-names">SR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Cheng</span>  <span class="cit-name-given-names">H-Y</span></span>, <span class="cit-auth"><span class="cit-name-surname">Smith</span>  <span class="cit-name-given-names">BR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Ward</span>  <span class="cit-name-given-names">KW</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kopple</span>  <span class="cit-name-given-names">KD</span></span>. <span class="cit-article-title">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span>. <abbr class="cit-jnl-abbrev">J Med Chem</abbr> <span class="cit-pub-date">2002</span>; <span class="cit-vol">45</span>: <span class="cit-fpage">2615</span>–<span class="cit-lpage">2623</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmedicinal%2Bchemistry%26rft.stitle%253DJ%2BMed%2BChem%26rft.aulast%253DVeber%26rft.auinit1%253DD.%2BF.%26rft.volume%253D45%26rft.issue%253D12%26rft.spage%253D2615%26rft.epage%253D2623%26rft.atitle%253DMolecular%2Bproperties%2Bthat%2Binfluence%2Bthe%2Boral%2Bbioavailability%2Bof%2Bdrug%2Bcandidates.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fjm020017n%26rft_id%253Dinfo%253Apmid%252F12036371%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/jm020017n&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12036371&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000175957700030&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[34].</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference [34] in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.34" data-doi="10.1023/A:1008130001697"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Oprea</span>  <span class="cit-name-given-names">TI</span></span>. <span class="cit-article-title">Property distribution of drug-related chemical databases</span>. <abbr class="cit-jnl-abbrev">J Comput Aided Mol Des</abbr> <span class="cit-pub-date">2000</span>; <span class="cit-vol">14</span>: <span class="cit-fpage">251</span>–<span class="cit-lpage">64</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bcomputer-aided%2Bmolecular%2Bdesign%26rft.stitle%253DJ%2BComput%2BAided%2BMol%2BDes%26rft.aulast%253DOprea%26rft.auinit1%253DT.%2BI.%26rft.volume%253D14%26rft.issue%253D3%26rft.spage%253D251%26rft.epage%253D264%26rft.atitle%253DProperty%2Bdistribution%2Bof%2Bdrug-related%2Bchemical%2Bdatabases.%26rft_id%253Dinfo%253Adoi%252F10.1023%252FA%253A1008130001697%26rft_id%253Dinfo%253Apmid%252F10756480%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1023/A:1008130001697&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=10756480&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000085573200004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">[35].</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference [35] in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.35" data-doi="10.1038/nchem.1243"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bickerton</span>  <span class="cit-name-given-names">GR</span></span>, <span class="cit-auth"><span class="cit-name-surname">Paolini</span>  <span class="cit-name-given-names">G V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Besnard</span>  <span class="cit-name-given-names">J</span></span>, <span class="cit-auth"><span class="cit-name-surname">Muresan</span>  <span class="cit-name-given-names">S</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hopkins</span>  <span class="cit-name-given-names">AL</span></span>. <span class="cit-article-title">Quantifying the chemical beauty of drugs</span>. <abbr class="cit-jnl-abbrev">Nat Chem</abbr> <span class="cit-pub-date">2012</span>; <span class="cit-vol">4</span>: <span class="cit-fpage">90</span>–<span class="cit-lpage">98</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.stitle%253DNat%2BChem%26rft.aulast%253DBickerton%26rft.auinit1%253DG.%2BR.%26rft.volume%253D4%26rft.issue%253D2%26rft.spage%253D90%26rft.epage%253D98%26rft.atitle%253DQuantifying%2Bthe%2Bchemical%2Bbeauty%2Bof%2Bdrugs.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnchem.1243%26rft_id%253Dinfo%253Apmid%252F22270643%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nchem.1243&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22270643&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">[36].</span><a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference [36] in text" id="ref-36">↵</a><div class="cit ref-cit ref-journal" id="cit-2020.03.12.977918v1.36" data-doi="10.1021/cc9800071"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Ghose</span>  <span class="cit-name-given-names">AK</span></span>, <span class="cit-auth"><span class="cit-name-surname">Viswanadhan</span>  <span class="cit-name-given-names">VN</span></span>, <span class="cit-auth"><span class="cit-name-surname">Wendoloski</span>  <span class="cit-name-given-names">JJ</span></span>. <span class="cit-article-title">A Knowledge-Based Approach in Designing Combinatorial or Medicinal Chemistry Libraries for Drug Discovery. 1. A Qualitative and Quantitative Characterization of Known Drug Databases</span>. <abbr class="cit-jnl-abbrev">J Comb Chem</abbr> <span class="cit-pub-date">1999</span>; <span class="cit-vol">1</span>: <span class="cit-fpage">55</span>–<span class="cit-lpage">68</span>.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bcombinatorial%2Bchemistry%26rft.stitle%253DJ%2BComb%2BChem%26rft.aulast%253DGhose%26rft.auinit1%253DA.%2BK.%26rft.volume%253D1%26rft.issue%253D1%26rft.spage%253D55%26rft.epage%253D68%26rft.atitle%253DA%2Bknowledge-based%2Bapproach%2Bin%2Bdesigning%2Bcombinatorial%2Bor%2Bmedicinal%2Bchemistry%2Blibraries%2Bfor%2Bdrug%2Bdiscovery.%2B1.%2BA%2Bqualitative%2Band%2Bquantitative%2Bcharacterization%2Bof%2Bknown%2Bdrug%2Bdatabases.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fcc9800071%26rft_id%253Dinfo%253Apmid%252F10746014%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/cc9800071&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=10746014&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F12%2F2020.03.12.977918.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000081367300007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F2020.03.12.977918v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/2020.03.12.988147v1" title="A family of viral satellites manipulates invading virus gene expression and affects cholera toxin mobilization" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/2020.03.02.974246v2" title="Multi-dimensional predictions of psychotic symptoms via machine learning" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;March 12, 2020.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/2020.03.12.977918v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/2020.03.12.977918v1.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/2020.03.12.977918v1" class="active" data-icon-position="" data-hide-link-title="0">A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/1193413" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-jWOWwTfQQcb8LnCZW7meEoojbKDUYoYT1ULaUn3kwk4" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1193413" id="node1193413" data-pisa="biorxiv;2020.03.12.977918v1" data-pisa-master="biorxiv;2020.03.12.977918" data-seqnum="1193413" data-apath="/biorxiv/early/2020/03/12/2020.03.12.977918.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Nishi</span> <span class="nlm-surname">Kumari</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Ayush</span> <span class="nlm-surname">Upadhyay</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Kishan</span> <span class="nlm-surname">Kalia</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Rakesh</span> <span class="nlm-surname">Kumar</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kanika</span> <span class="nlm-surname">Tuteja</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Priyanka Rani</span> <span class="nlm-surname">Paul</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Eugenia</span> <span class="nlm-surname">Covernton</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Tina</span> <span class="nlm-surname">Sharma</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Vinod</span> <span class="nlm-surname">Scaria</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Anshu</span> <span class="nlm-surname">Bhardwaj</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.03.12.977918; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.03.12.977918 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;title=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;title=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;text=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;title=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;t=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;title=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;title=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="1193413" id="node1193413--2" data-pisa="biorxiv;2020.03.12.977918v1" data-pisa-master="biorxiv;2020.03.12.977918" data-seqnum="1193413" data-apath="/biorxiv/early/2020/03/12/2020.03.12.977918.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">A Combined Evidence Approach to Prioritize Nipah Virus Inhibitors</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Nishi</span> <span class="nlm-surname">Kumari</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Ayush</span> <span class="nlm-surname">Upadhyay</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Kishan</span> <span class="nlm-surname">Kalia</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Rakesh</span> <span class="nlm-surname">Kumar</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Kanika</span> <span class="nlm-surname">Tuteja</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Priyanka Rani</span> <span class="nlm-surname">Paul</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Eugenia</span> <span class="nlm-surname">Covernton</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Tina</span> <span class="nlm-surname">Sharma</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">Vinod</span> <span class="nlm-surname">Scaria</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Anshu</span> <span class="nlm-surname">Bhardwaj</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">2020.03.12.977918; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/2020.03.12.977918 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors&amp;rft.volume&amp;rft.issue&amp;rft.date=2020-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Kumari%2C+Nishi&amp;rft.au=Upadhyay%2C+Ayush&amp;rft.au=Kalia%2C+Kishan&amp;rft.au=Kumar%2C+Rakesh&amp;rft.au=Tuteja%2C+Kanika&amp;rft.au=Paul%2C+Priyanka+Rani&amp;rft.au=Covernton%2C+Eugenia&amp;rft.au=Sharma%2C+Tina&amp;rft.au=Scaria%2C+Vinod&amp;rft.au=Bhardwaj%2C+Anshu"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/1193413/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/1193413/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/1193413/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/1193413/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/1193413/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/1193413/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/1193413/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/1193413/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/1193413/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/1193413/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/1193413/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/1193413/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;count=horizontal&amp;via=&amp;text=A%20Combined%20Evidence%20Approach%20to%20Prioritize%20Nipah%20Virus%20Inhibitors&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/2020.03.12.977918v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/2020.03.12.977918v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/bioinformatics" class="highlight" data-icon-position="" data-hide-link-title="0">Bioinformatics<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20276)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__N7ERJBYsOWyRnJgyoM125_Aiez2MOJGaUofG1JdWWBg__bLlcwhzZhT-IwoQ_dvm1_xPxU7E7gecFLC6Fyeqtv8s__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
